Literature DB >> 6150174

Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment.

T A Howlett, N F Lawton, P Fells, G M Besser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150174     DOI: 10.1016/s0140-6736(84)91541-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Ocular manifestations of Graves' disease.

Authors:  W Kelly; R Cove-Smith; A Rashid
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

Review 2.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

3.  Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.

Authors:  M Estrin; S A Huber
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

4.  Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study.

Authors:  A A Drosos; F N Skopouli; J S Costopoulos; C S Papadimitriou; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

5.  Treatment of Graves' ophthalmopathy with cyclosporin A.

Authors:  A Witte; R Landgraf; A Markl; K P Boergen; G Hasenfratz; C R Pickardt
Journal:  Klin Wochenschr       Date:  1985-10-01

6.  Combined irradiation and low-dose cyclophosphamide in the treatment of Graves' ophthalmopathy.

Authors:  R Teoh; J Woo
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.